Pricing Log in Create free account
Friday 6 November 2026 Export SNN’s income statement to Excel — free account

Smith & Nephew SNATS, Inc.

SNN Healthcare Medical Devices

Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.

31.12 0.89 −2.78%
Market cap
$13.4B
P/E
38.9×
Fwd P/E
18.9×
Dividend yield
2.49%
F-score
7/9
Altman Z
3.49
Beneish M
−2.70
Dividend safety
61/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Smith & Nephew SNATS, Inc. (SNN) Revenue

Alert me on Revenue

Smith & Nephew SNATS, Inc.'s revenue for fiscal 2025 was $6.2B, up 6.09% from $5.8B in fiscal 2024. Over the past ten years it has ranged from $4.6B (fiscal 2020) to $6.2B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. Smith & Nephew SNATS, Inc. ranks 7th of 140 Medical Devices companies by revenue.

Revenue, annual

Embed this chart

Annual newest first

Period Revenue Change
FY2025 $6.2B 6.09%
FY2024 $5.8B 4.70%
FY2023 $5.5B 6.40%
FY2022 $5.2B 0.06%
FY2021 $5.2B 14.30%
FY2020 $4.6B (11.25%)
FY2019 $5.1B 4.77%
FY2018 $4.9B 2.92%
FY2017 $4.8B 2.06%
FY2016 $4.7B 0.76%

Against its own ten years

Low $4.6B High $6.2B
Ten-year median $5.1B
Current reading's percentile 100

Revenue against peers

Company Revenue
SNN Smith & Nephew SNATS, Inc. $10.5B
BRKR Bruker Corporation compare $3.5B
PODD Insulet Corporation compare $3.2B
GMED Globus Medical, Inc. compare $3.1B
BIO.B Bio-Rad Laboratories, Inc. compare $2.6B
BIO Bio-Rad Laboratories, Inc. compare $2.6B
PEN Penumbra, Inc. compare $1.6B
GKOS Glaukos Corporation compare $690.3M
TXG 10x Genomics compare $616.9M

What Revenue is

Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.

Reported line item

The full definition of Revenue →

More on SNN